BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:alprostadil readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of alprostadil\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07842120-618@assetmemo.bio
DTSTAMP:20261121T004038Z
DTSTART;VALUE=DATE:20261230
DTEND;VALUE=DATE:20261231
SUMMARY:alprostadil: Phase 2 readout est. (NCT07842120)
DESCRIPTION:alprostadil\, phase 2.\nStudy: Comparing MOP\, Prostaglandin E1
 \, and Calcitriol to Accelerate Orthodontic Tooth Movement\nEstimated prim
 ary completion: 30 December 2026. This is a ClinicalTrials.gov estimate\, 
 not a confirmed readout date\, and it can move.\nDrug page: https://assetm
 emo.bio/drug/alprostadil#upcoming-events\nRegistry record: https://clinica
 ltrials.gov/study/NCT07842120
URL:https://assetmemo.bio/drug/alprostadil#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07601646-618@assetmemo.bio
DTSTAMP:20261121T004038Z
DTSTART;VALUE=DATE:20270430
DTEND;VALUE=DATE:20270501
SUMMARY:alprostadil: Phase 2 readout est. (NCT07601646)
DESCRIPTION:alprostadil\, phase 2.\nStudy: A Single-Arm\, Dose Escalation o
 f an Intraurethral Alprostadil Paste for Erectile Dysfunction\nEstimated p
 rimary completion: April 2027. This is a ClinicalTrials.gov estimate\, not
  a confirmed readout date\, and it can move.\nDrug page: https://assetmemo
 .bio/drug/alprostadil#upcoming-events\nRegistry record: https://clinicaltr
 ials.gov/study/NCT07601646
URL:https://assetmemo.bio/drug/alprostadil#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT00610051-618@assetmemo.bio
DTSTAMP:20261121T004038Z
DTSTART;VALUE=DATE:20291130
DTEND;VALUE=DATE:20291201
SUMMARY:alprostadil: Phase 3 readout est. (NCT00610051)
DESCRIPTION:alprostadil\, phase 3\, Heart Failure.\nStudy: ALP-1 Continuous
  Intravenous Infusion to Maintain Clinical Stability in Advanced Heart Fai
 lure\nEstimated primary completion: November 2029. This is a ClinicalTrial
 s.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pag
 e: https://assetmemo.bio/drug/alprostadil#upcoming-events\nRegistry record
 : https://clinicaltrials.gov/study/NCT00610051
URL:https://assetmemo.bio/drug/alprostadil#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
